The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response
Authors
Keywords
Antibodies, Vaccines, T cells, Dengue virus, Antibody response, B cells, Cell-mediated immunity, Flaviviruses
Journal
PLoS Neglected Tropical Diseases
Volume 9, Issue 6, Pages e0003749
Publisher
Public Library of Science (PLoS)
Online
2015-06-12
DOI
10.1371/journal.pntd.0003749
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibodies against Immature Virions Are Not a Discriminating Factor for Dengue Disease Severity
- (2015) Izabela A. Rodenhuis-Zybert et al. PLoS Neglected Tropical Diseases
- Sequential Episodes of Dengue—Puerto Rico, 2005–2010
- (2014) Tyler M. Sharp et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Research on Dengue During World War II Revisited
- (2014) Grace E. Snow et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Variation of the Specificity of the Human Antibody Responses after Tick-Borne Encephalitis Virus Infection and Vaccination
- (2014) J. Jarmer et al. JOURNAL OF VIROLOGY
- Isolation of Dengue Virus-Specific Memory B Cells with Live Virus Antigen from Human Subjects following Natural Infection Reveals the Presence of Diverse Novel Functional Groups of Antibody Clones
- (2014) S. A. Smith et al. JOURNAL OF VIROLOGY
- The Human CD8+T Cell Responses Induced by a Live Attenuated Tetravalent Dengue Vaccine Are Directed against Highly Conserved Epitopes
- (2014) Daniela Weiskopf et al. JOURNAL OF VIROLOGY
- Dengue vaccines: dawning at last?
- (2014) Annelies Wilder-Smith LANCET
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus
- (2014) Wanwisa Dejnirattisai et al. NATURE IMMUNOLOGY
- Dengue virus envelope protein domain I/II hinge determines long-lived serotype-specific dengue immunity
- (2014) William B. Messer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Dengue virus infection-enhancing activity of undiluted sera obtained from patients with secondary dengue virus infection
- (2014) M. L. Moi et al. TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
- Safety, immunogenicity and efficacy of a recombinant tetravalent dengue vaccine: A meta-analysis of randomized trials
- (2014) Vivaldo G. da Costa et al. VACCINE
- Plaque reduction neutralization antibody test does not accurately predict protection against dengue infection in Ratchaburi cohort, Thailand
- (2014) Chukiat Sirivichayakul et al. Virology Journal
- Assessment of bivalent and tetravalent dengue vaccine formulations in flavivirus-naïve adults in Mexico
- (2014) Gustavo H Dayan et al. Human Vaccines & Immunotherapeutics
- Variability in Dengue Titer Estimates from Plaque Reduction Neutralization Tests Poses a Challenge to Epidemiological Studies and Vaccine Development
- (2014) Henrik Salje et al. PLoS Neglected Tropical Diseases
- Dengue Virus Neutralizing Antibody Levels Associated with Protection from Infection in Thai Cluster Studies
- (2014) Darunee Buddhari et al. PLoS Neglected Tropical Diseases
- Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
- (2014) Ruklanthi de Alwis et al. PLoS Pathogens
- T-Cell Immunity to Infection with Dengue Virus in Humans
- (2014) Daniela Weiskopf et al. Frontiers in Immunology
- Dengue virus envelope domain III immunization elicits predominantly cross-reactive, poorly neutralizing antibodies localized to the AB loop: implications for dengue vaccine design
- (2013) X.-Q. Li et al. JOURNAL OF GENERAL VIROLOGY
- Human Monoclonal Antibodies Derived From Memory B Cells Following Live Attenuated Dengue Virus Vaccination or Natural Infection Exhibit Similar Characteristics
- (2013) Scott A. Smith et al. JOURNAL OF INFECTIOUS DISEASES
- A Shorter Time Interval Between First and Second Dengue Infections Is Associated With Protection From Clinical Illness in a School-based Cohort in Thailand
- (2013) Kathryn B. Anderson et al. JOURNAL OF INFECTIOUS DISEASES
- High-Avidity and Potently Neutralizing Cross-Reactive Human Monoclonal Antibodies Derived from Secondary Dengue Virus Infection
- (2013) Wen-Yang Tsai et al. JOURNAL OF VIROLOGY
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Safety and Immunogenicity of a Recombinant Tetravalent Dengue Vaccine in 9–16 Year Olds
- (2013) Luis Á. Villar et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- First Evidence of Simultaneous Circulation of Three Different Dengue Virus Serotypes in Africa
- (2013) Melanie Caron et al. PLoS One
- Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells
- (2013) D. Weiskopf et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Safety and immunogenicity of a tetravalent dengue vaccine in healthy children aged 2–11 years in Malaysia: A randomized, placebo-controlled, Phase III study
- (2013) Amar-Singh HSS et al. VACCINE
- The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein
- (2013) S. A. Smith et al. mBio
- Persistence of Th1/Tc1 responses one year after tetravalent dengue vaccination in adults and adolescents in Singapore
- (2013) Anke Harenberg et al. Human Vaccines & Immunotherapeutics
- Frequent In-Migration and Highly Focal Transmission of Dengue Viruses among Children in Kamphaeng Phet, Thailand
- (2013) Maia A. Rabaa et al. PLoS Neglected Tropical Diseases
- Host Cell Transcriptome Profile during Wild-Type and Attenuated Dengue Virus Infection
- (2013) October M. Sessions et al. PLoS Neglected Tropical Diseases
- Symptomatic Versus Inapparent Outcome in Repeat Dengue Virus Infections Is Influenced by the Time Interval between Infections and Study Year
- (2013) Magelda Montoya et al. PLoS Neglected Tropical Diseases
- Analysis of Cross-Reactive Antibodies Recognizing the Fusion Loop of Envelope Protein and Correlation with Neutralizing Antibody Titers in Nicaraguan Dengue Cases
- (2013) Chih-Yun Lai et al. PLoS Neglected Tropical Diseases
- Role of Humoral versus Cellular Responses Induced by a Protective Dengue Vaccine Candidate
- (2013) Raphaël M. Zellweger et al. PLoS Pathogens
- Dissection of Antibody Specificities Induced by Yellow Fever Vaccination
- (2013) Oksana Vratskikh et al. PLoS Pathogens
- Human monoclonal antibodies to neutralize all dengue virus serotypes using lymphocytes from patients at acute phase of the secondary infection
- (2012) Chayanee Setthapramote et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Variation in dengue virus plaque reduction neutralization testing: systematic review and pooled analysis
- (2012) Kaitlin Rainwater-Lovett et al. BMC INFECTIOUS DISEASES
- Cross-Protective Capacity of Japanese Encephalitis (JE) Vaccines Against Circulating Heterologous JE Virus Genotypes
- (2012) Elina O. Erra et al. CLINICAL INFECTIOUS DISEASES
- Phage Display Approaches for the Isolation of Monoclonal Antibodies Against Dengue Virus Envelope Domain III from Human and Mouse Derived Libraries
- (2012) Nicole J. Moreland et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Recombinant Dengue Type 2 Viruses with Altered E Protein Domain III Epitopes Are Efficiently Neutralized by Human Immune Sera
- (2012) W. M. P. B. Wahala et al. JOURNAL OF VIROLOGY
- Dengue vaccine development: a 75% solution?
- (2012) Scott B Halstead LANCET
- Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial
- (2012) Arunee Sabchareon et al. LANCET
- Dengue virus infection-enhancing and neutralizing antibody balance in children of the Philippines and Indonesia
- (2012) Atsushi Yamanaka et al. MICROBES AND INFECTION
- Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions
- (2012) R. de Alwis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Mechanisms Involved in Antibody-Dependent Enhancement of Dengue Virus Infection in Humans
- (2012) Jacky Flipse et al. TRAFFIC
- Flaviviruses and flavivirus vaccines
- (2012) Franz X. Heinz et al. VACCINE
- Dominant Cross-Reactive B Cell Response during Secondary Acute Dengue Virus Infection in Humans
- (2012) Simona Zompi et al. PLoS Neglected Tropical Diseases
- Phylogenetic relationships of Western Mediterranean West Nile virus strains (1996-2010) using full-length genome sequences: single or multiple introductions?
- (2011) E. Sotelo et al. JOURNAL OF GENERAL VIROLOGY
- B-Cell Responses During Primary and Secondary Dengue Virus Infections in Humans
- (2011) Anuja Mathew et al. JOURNAL OF INFECTIOUS DISEASES
- Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
- (2011) S. A. Smith et al. JOURNAL OF VIROLOGY
- Neuroinvasive flavivirus infections
- (2011) Gregorius J. Sips et al. REVIEWS IN MEDICAL VIROLOGY
- From research to phase III: Preclinical, industrial and clinical development of the Sanofi Pasteur tetravalent dengue vaccine
- (2011) Bruno Guy et al. VACCINE
- In-Depth Analysis of the Antibody Response of Individuals Exposed to Primary Dengue Virus Infection
- (2011) Ruklanthi de Alwis et al. PLoS Neglected Tropical Diseases
- A Dynamic Landscape for Antibody Binding Modulates Antibody-Mediated Neutralization of West Nile Virus
- (2011) Kimberly A. Dowd et al. PLoS Pathogens
- The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity
- (2010) Martina Beltramello et al. Cell Host & Microbe
- Correlates of Protection Induced by Vaccination
- (2010) S. A. Plotkin Clinical and Vaccine Immunology
- Different Innate Signatures Induced in Human Monocyte-derived Dendritic Cells by Wild-Type Dengue 3 Virus, Attenuated but Reactogenic Dengue 3 Vaccine Virus, or Attenuated Nonreactogenic Dengue 1-4 Vaccine Virus Strains
- (2010) C. Balas et al. JOURNAL OF INFECTIOUS DISEASES
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
- (2010) James D. Brien et al. JOURNAL OF VIROLOGY
- An In-Depth Analysis of Original Antigenic Sin in Dengue Virus Infection
- (2010) C. M. Midgley et al. JOURNAL OF VIROLOGY
- Intrinsic antibody-dependent enhancement of microbial infection in macrophages: disease regulation by immune complexes
- (2010) Scott B Halstead et al. LANCET INFECTIOUS DISEASES
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Immature Dengue Virus: A Veiled Pathogen?
- (2010) Izabela A. Rodenhuis-Zybert et al. PLoS Pathogens
- Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
- (2010) Wahala M. P. B. Wahala et al. PLoS Pathogens
- Dengue Plaque Reduction Neutralization Test (PRNT) in Primary and Secondary Dengue Virus Infections: How Alterations in Assay Conditions Impact Performance
- (2009) Stephen J. Thomas et al. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
- Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens
- (2009) Wayne D. Crill et al. PLoS One
- Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody
- (2009) W.M.P.B. Wahala et al. VIROLOGY
- Structural Insights into the Mechanisms of Antibody-Mediated Neutralization of Flavivirus Infection: Implications for Vaccine Development
- (2008) Theodore C. Pierson et al. Cell Host & Microbe
- Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II
- (2008) C.-Y. Lai et al. JOURNAL OF VIROLOGY
- Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- (2008) Bruno Guy et al. VACCINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More